Financial Performance - Q4 FY25 revenue was $225.5 million, a decrease from $236.8 million in Q4 FY24[11] - Adjusted EBITDA for Q4 FY25 was $40.6 million, compared to $53.0 million in Q4 FY24, with a margin of 18.0% versus 22.4%[12] - Adjusted net income decreased to $11.3 million ($0.05 per share) in Q4 FY25 from $22.4 million ($0.10 per share) in Q4 FY24[13] - Core revenue growth in the Food Safety segment was (1.3)%, while the Animal Safety segment experienced a core revenue growth of (6.7)%[15] Balance Sheet and Capital Allocation - As of May 31, 2025, gross debt was $900 million and net debt was $771 million[17] - Pro forma net debt, after accounting for cash and equivalents, is $656 million with gross debt at $800 million[17] - Net proceeds from the Cleaners & Disinfectants divestiture were approximately $115 million, with $100 million allocated for debt paydown in Q1[19] FY26 Outlook - The company anticipates FY26 revenue to be between $820 million and $840 million[21] - Adjusted EBITDA is projected to be in the range of $165 million to $175 million[21] - Capital expenditures are estimated to be around $50 million, including approximately $35 million for integration-related expenses[21]